Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital

NCT00192933 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2006-10-19

No results posted yet for this study

Summary

The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Conditions

Interventions

PROCEDURE

NovoSeven treatment according to guideline

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Pär Johansson, MD, MPA · Blood Bank, Rigshospitalet, Copenhagen University Hospital

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Completion
2010-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00192933 on ClinicalTrials.gov